Flufenamic acid in rheumatoid arthritis.

Abstract
A double-blind clinical trial comparing flufenamic acid, aspirin, and phenylbutazone fa patients with rheumatoid arthritis failed to reveal any difference between these drugs fa their ability to relieve symptoms, improve strength of grip, or reduce the erythrocyte sedimentation rate.